MINT-MEXILETINE 200 MG
MEXILETINE HYDROCHLORIDE : 200 MG · DIN 02536854 · MINT PHARMACEUTICALS INC
Health Canada status: MARKETED
What is MINT-MEXILETINE?
MINT-MEXILETINE 200 MG contains MEXILETINE HYDROCHLORIDE : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02536854, held by MINT PHARMACEUTICALS INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 18-Jan-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02536854 |
|---|---|
| Brand name | MINT-MEXILETINE |
| Generic / active ingredient | MEXILETINE HYDROCHLORIDE : 200 MG |
| Manufacturer | MINT PHARMACEUTICALS INC |
| Strength | 200 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C01BB02 MEXILETINE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 18-Jan-2024 |
What can be used instead?
Other Canadian products sharing ATC code C01BB02 MEXILETINE. 4 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MINT-MEXILETINE | 100 MG | CAPSULE | MINT PHARMACEUTICALS INC | MARKETED | DIN 02536846 |
| TEVA-MEXILETINE | 100 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | DIN 02230359 |
| TEVA-MEXILETINE | 200 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | DIN 02230360 |
| ALTI-MEXILETINE | 100 MG | CAPSULE | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02231690 |
| ALTI-MEXILETINE | 200 MG | CAPSULE | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02231692 |
| MEXITIL CAP 100MG | 100 MG | CAPSULE | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | CANCELLED POST MARKET | DIN 00599956 |
| MEXITIL CAP 200MG | 200 MG | CAPSULE | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | CANCELLED POST MARKET | DIN 00599964 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.